Chong‐Rui Xu
- Pulmonary and Respiratory Medicine top 0.5%
- Oncology top 0.5%
- Molecular Biology top 10%
- Cancer Research top 2%
- Radiology, Nuclear Medicine and Imaging top 5%
- Topics
- Lung Cancer Treatments and Mutations (83 papers)Lung Cancer Research Studies (33 papers)Colorectal Cancer Treatments and Studies (29 papers)
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaCancer Cell
- Partner nations
- ChinaUnited StatesIndia
In The Last Decade
Chong‐Rui Xu
112 papers receiving 4.3k citations
Hit Papers
Peers
Comparison fields: 5 of 92
- Pulmonary and Respiratory Medicine 3.5k
- Oncology 3.1k
- Molecular Biology 1.0k
- Cancer Research 931
- Radiology, Nuclear Medicine and Imaging 299
Countries citing papers authored by Chong‐Rui Xu
This map shows the geographic impact of Chong‐Rui Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chong‐Rui Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chong‐Rui Xu more than expected).
Fields of papers citing papers by Chong‐Rui Xu
This network shows the impact of papers produced by Chong‐Rui Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chong‐Rui Xu. The network helps show where Chong‐Rui Xu may publish in the future.
Co-authorship network of co-authors of Chong‐Rui Xu
This figure shows the co-authorship network connecting the top 25 collaborators of Chong‐Rui Xu. A scholar is included among the top collaborators of Chong‐Rui Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chong‐Rui Xu. Chong‐Rui Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 3 | |
| 3 | 3 | |
| 4 | 0 | |
| 5 | 1 | |
| 6 | 2 | |
| 7 | 0 | |
| 8 | 2 | |
| 9 | 11 | |
| 10 | 2 | |
| 11 | 0 | |
| 12 | 1 | |
| 13 | 23 | |
| 14 | 1 | |
| 15 | 19 | |
| 16 | 144 | |
| 17 | Prognostic Value and Potential Biological Functions of CLDN8 in Patients with Clear Cell Renal Cell Carcinoma | 1 |
| 18 | 42 | |
| 19 | 0 | |
| 20 | 135 |
About Chong‐Rui Xu
Chong‐Rui Xu is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research, having authored 122 papers that have together received 4.4k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (83 papers), Lung Cancer Research Studies (33 papers) and Colorectal Cancer Treatments and Studies (29 papers). The work is most often cited by research in Oncology (3.1k citations), Pulmonary and Respiratory Medicine (3.5k citations) and Cancer Research (931 citations). Chong‐Rui Xu has collaborated with scholars based in China, United States and India. Frequent co-authors include Yi‐Long Wu, Qing Zhou, Shun Lü, Jian Hua Shi, Jifeng Feng, Yunchao Huang, Mei Hou, Wen‐Zhao Zhong, Chengping Hu and Caicun Zhou. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.